Superiority Trial Evaluating Digitalized Information Media for Patients With Advanced Sarcomas Receiving Systemic Treatment.

This study tests whether a digital information tool (such as an app or online platform) helps patients with advanced sarcoma (a type of cancer affecting soft tissues, bones, or organs) better understand and manage their treatment compared to standard paper-based materials. Better-informed patients often have better outcomes and quality of life. **You may be eligible if...** - You have a diagnosis of soft tissue or visceral sarcoma that is inoperable, metastatic, or locally advanced - Your doctor has recommended systemic treatment with one of these drugs: pazopanib, trabectedine, eribulin, ifosfamide, or dacarbazine - You are covered by French social security - You have signed informed consent **You may NOT be eligible if...** - You have previously enrolled in this trial for a different line of treatment - You do not meet the criteria for the specific drugs listed - You are not covered by French social security Talk to your doctor to see if this trial is right for you.